| Bacterial strain |
Gram stain |
Types of infections |
Reference |
| Staphylococcus aureus |
Gram-positive |
Chronic biofilm infections, right valve endocarditis, chronic wound infection, lung infections in patients with cystic fibrosis |
10-12
|
| Staphylococcus epidermidis |
Gram-positive |
Endocarditis, catheter-related infection, joint prosthesis infection |
13-15
|
| Streptococcus pneumoniae |
Gram-positive |
Lung infections, bacterial meningitis, acute or chronic otitis media |
16
|
| Listeria monocytogenes |
Gram-positive |
Co-culture interactions with Pseudomonas, Vibrio strains, listeriosis, contamination of food products |
17,18
|
| Burkholderia cepacia |
Gram-negative |
Opportunistic infections in patients with blood cancer |
19
|
| Escherichia coli |
Gram-negative |
Hemolytic uremic syndrome, acute diarrheic syndrome, urinary tract infections |
20
|
| Klebsiella pneumoniae |
Gram-negative |
Bacteremia, liver abscess, urinary tract infections |
21
|
| Pseudomonas putida |
Gram-negative |
Urinary tract infection |
22,23
|
| Pseudomonas aeruginosa |
Gram-negative |
Osteomyelitis, ventilator-associated pneumonia, lung infections in patients with cystic fibrosis, opportunistic infections in neutropenic patients, nosocomial infections |
10
|
| Pseudomonas fluorescens |
Gram-negative |
Bioremediation, biocontrol- Pythium, Fusarium, antimicrobial properties – production of mupirocin |
17,24-26
|
| Rhizobium leguminosarum |
Gram-negative |
Biocontrol properties – Pythium |
27
|
| Lactobacillus plantarum |
Gram-positive |
Prevention of Salmonella infection |
22,28
|
| Lactococcus lactis |
Gram-positive |
Antimicrobial properties in the human gastro-intestinal tract |
29
|